Jian Hua Mo
Director/Board Member at HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Net worth: 173 M $ as of 2024-04-29
Profile
Mr. Jian Hua Mo is a General Manager at Hangzhou Pute Equity Investment Management Ltd.
and an Executive Director & General Manager at Hangzhou Binpu Real Estate Development Ltd.
He is on the Board of Directors at Binjiang Service Group Co. Ltd., Hangzhou Binjiang Real Estate Group Co., Ltd., Shanghai Binshun Investment Management Ltd and Hangzhou Binpu Real Estate Development Ltd.
Mr. Mo was previously employed as a General Manager by Hangzhou Binjiang Venture Captal Investment Ltd.
and a Deputy General Manager by Hangzhou Binjiang Real Estate Construction Co. Ltd.
He also served on the board at Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
He received his MBA from Zhejiang University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-29 | 35,640,000 ( 12.89% ) | 80 M $ | 2024-04-29 | |
| 2023-09-29 | 75,195,600 ( 17.52% ) | 70 M $ | 2024-04-29 | |
| 2023-09-29 | 25,065,200 ( 0.93% ) | 23 M $ | 2024-04-29 |
Jian Hua Mo active positions
| Companies | Position | Start |
|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Director/Board Member | 2012-04-30 |
| BINJIANG SERVICE GROUP CO. LTD. | Director/Board Member | 2017-11-30 |
| Shanghai Binshun Investment Management Ltd | Director/Board Member | - |
| Hangzhou Binpu Real Estate Development Ltd. | Director/Board Member | - |
| Hangzhou Pute Equity Investment Management Ltd. | Corporate Officer/Principal | 2016-12-31 |
Former positions of Jian Hua Mo
| Companies | Position | End |
|---|---|---|
| Hangzhou Binjiang Venture Captal Investment Ltd. | Corporate Officer/Principal | 2017-10-31 |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. | Corporate Officer/Principal | 1999-11-30 |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Director/Board Member | - |
Training of Jian Hua Mo
| Zhejiang University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| BINJIANG SERVICE GROUP CO. LTD. | Finance |
| Private companies | 6 |
|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Shanghai Binshun Investment Management Ltd | |
| Hangzhou Binpu Real Estate Development Ltd. | |
| Hangzhou Pute Equity Investment Management Ltd. | |
| Hangzhou Binjiang Venture Captal Investment Ltd. | |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. |
- Stock Market
- Insiders
- Jian Hua Mo
